Skip to main content

Table 2 Clinical characteristics of 32 patients and their outcome

From: Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience

Patient number

Age range at presentation

Age range at metastases

Tumor diameter (cm)

pT-stage

pN-stage

M-stage

Site of metastases

Tg at diagnosis of metastases

Survival

Disease-free interval

Survival from diagnosis of distant metastases

Cause of death

1

85–89

85–89

7,5

3

0

1

L

7414

77

0

77

DDM

2

75–79

75–79

5

4b

0

1

L

4450

53

0

53

DOC

3

70–74

70–74

8

3

0

1

L

265

141

0

141

DDM

4

70–74

70–74

6

4a

0

1

B

183

13

0

13

DDM

5

65–69

65–69

8,5

3

0

1

L

16650

185

0

185

Alive

6

65–69

65–69

8

3

0

1

BL

4010

148

0

148

DDM

7

60–64

60–64

8

0

0

1

B

No data

153

0

153

DDM

8

60–64

60–64

4,5

3

1b

1

L

62600

131

0

131

DDM

9

60–64

60–64

2

2

0

1

B

69

1

0

1

LFU

10

60–64

60–64

6,5

3

0

1

L

1300

72

0

72

DDM

11

55–59

55–59

5

4b

1b

1

L

190

201

0

201

DDM

12

45–49

45–49

9

4b

0

1

L

5800

52

0

52

DDM

13

85–89

85–89

12

3

0

0

Mediastinum

277

52

38

14

DDM

14

75–79

75–79

3

2

0

0

B

47

126

34

92

Alive

15

75–79

85–89

8

3

0

0

L

696

144

84

60

DDM

16

70–74

70–74

2

4a

1a

0

Kidney

1432

318

180

138

DDM

17

70–74

75–79

8

3

0

0

L

1300

63

36

2

DDLTP

18

70–74

80–84

6,8

3

0

0

L

1000

132

96

36

Alive

19

70–74

70–74

5,5

4a

0

0

L

No data

26

3

23

DDM

20

65–69

65–69

3,6

3

0

0

L

0.1

46

43

3

Alive

21

65–69

70–74

7

4a

0

0

L

No data

63

53

10

DDM

22

65–69

65–69

9

3

0

0

BL

1100

145

52

93

DDM

23

60–64

65–69

18

4b

1b

0

L

416

100

20

53

DDM

24

60–64

70–74

3

2

0

0

L, liver

501

121

84

36

DDM

25

60–64

65–69

4,5

3

0

0

L

30773

97

49

48

Alive

26

60–64

70–74

7

3

0

0

L

196

138

113

27

Alive

27

60–64

60–64

6,5

3

1a

0

B

763

43

16

27

Alive

28

60–64

60–64

8

4a

0

0

Mediastinum

1800

145

44

101

DDLTP

29

50–54

55–59

13

4b

0

0

L

800

75

26

42

DDM

30

50–54

75–79

6

3

0

0

L

163

337

31

65

DDM

31

50–54

50–54

3

2

1b

0

L

Tg-antibodies

33

9

24

Alive

32

35–39

40–44

4

3

0

0

BL

108

286

60

226

Alive

  1. Legend: B bone, L lungs, DDM dead of distant metastases, DOC dead of other causes, LFU lost to follow-up, DDLTP dead of distant and locoregional tumor progression